SCHEMBL23867514

SCHEMBL23867514

O=C(Cc1cccs1)Nc1ccc(Nc2ccnc(N3CCN(CCO)CC3)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 10/20 0.50
▸ ACHE P22303 3/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ IKBKB O14920 1/20 0.46
▸ MEN1 O00255 5/20 0.46
▸ KMT2A Q03164 5/20 0.46
▸ ESR2 Q92731 5/20 0.46
▸ L3MBTL1 Q9Y468 4/20 0.46
▸ HSD17B10 Q99714 4/20 0.46
▸ CTDSP1 Q9GZU7 4/20 0.46
▸ RECQL P46063 3/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ BLM P54132 2/20 0.46
▸ PKM P14618 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ ESR1 P03372 3/20 0.45
▸ DNMT1 P26358 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867475 0.88 POLB (0.55) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL23867479 0.85 POLB (0.49) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL23867573 0.85 PYGM (0.51) ACHESMN1; SMN2ALDH1A1
SCHEMBL23867515 0.84 POLB (0.47) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL23867474 0.83 SRC (0.51) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL23867525 0.80 HTR2A (0.49) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL23867512 0.75 ACHE (0.50) POLBACHESRCDRD2HTR2A
SCHEMBL23859942 0.73 POLB (0.55) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL23867516 0.72 POLB (0.53) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL30979648 0.72 POLB (0.66) POLBSMN1; SMN2NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback